Arkolith/Insider Trading/TSHA/Form 4

Alam Kamran

Chief Financial OfficerTaysha Gene Therapies, Inc. (TSHA) · full profile →Form 4 · filed Aug 25, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$77K
Net Open-Market Flow
-$77K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 24, 2023Sell(S)33K$2.33$77K258K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-047323) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML